Kaizen Financial Strategies Buys Shares of 400 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Kaizen Financial Strategies purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 400 shares of the medical equipment provider’s stock, valued at approximately $209,000.

Other institutional investors have also modified their holdings of the company. Atala Financial Inc purchased a new position in shares of Intuitive Surgical during the 4th quarter worth $25,000. Berbice Capital Management LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at $26,000. Parvin Asset Management LLC purchased a new position in Intuitive Surgical during the fourth quarter worth about $26,000. BankPlus Trust Department acquired a new stake in Intuitive Surgical in the 4th quarter worth about $28,000. Finally, Hurley Capital LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at about $28,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $536.55 on Friday. The company’s fifty day moving average price is $500.93 and its two-hundred day moving average price is $534.86. The firm has a market capitalization of $192.31 billion, a P/E ratio of 83.71, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 12 month low of $379.67 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. During the same quarter in the previous year, the firm posted $1.50 earnings per share. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity

In other news, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the sale, the executive vice president now owns 353 shares in the company, valued at approximately $208,181.75. This represents a 53.61 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the transaction, the chief financial officer now owns 3,282 shares of the company’s stock, valued at $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 33,313 shares of company stock worth $17,229,143. 0.70% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Evercore ISI decreased their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a report on Wednesday, April 23rd. Truist Financial dropped their price objective on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a report on Wednesday, April 23rd. Royal Bank of Canada reduced their target price on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a report on Wednesday, April 23rd. Finally, Citigroup upped their price target on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $598.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.